Susquehanna International Group
BEAM icon

Susquehanna International Group’s Beam Therapeutics BEAM Stock Holding History

Susquehanna International Group’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.24M Sell
177,800
-322,400
-64% -$8.95M ﹤0.01% 4552
2025
Q4 		$13.9M Buy
500,200
+200,400
+67% +$5.11M ﹤0.01% 2639
2025
Q3 		$7.28M Buy
299,800
+90,500
+43% +$1.8M ﹤0.01% 3494
2025
Q2 		$3.56M Sell
209,300
-84,200
-29% -$1.47M ﹤0.01% 4632
2025
Q1 		$5.73M Buy
293,500
+159,900
+120% +$4.19M ﹤0.01% 3395
2024
Q4 		$3.31M Sell
133,600
-91,000
-41% -$2.32M ﹤0.01% 4284
2024
Q3 		$5.5M Buy
224,600
+132,200
+143% +$3.42M ﹤0.01% 3449
2024
Q2 		$2.16M Sell
92,400
-10,300
-10% -$253K ﹤0.01% 4950
2024
Q1 		$3.39M Sell
102,700
-30,500
-23% -$950K ﹤0.01% 4272
2023
Q4 		$3.63M Buy
133,200
+61,400
+86% +$1.53M ﹤0.01% 4267
2023
Q3 		$1.73M Sell
71,800
-118,000
-62% -$3.16M ﹤0.01% 5438
2023
Q2 		$6.06M Buy
189,800
+92,100
+94% +$2.99M ﹤0.01% 3216
2023
Q1 		$2.99M Buy
97,700
+41,500
+74% +$1.64M ﹤0.01% 4331
2022
Q4 		$2.2M Sell
56,200
-334,900
-86% -$15M ﹤0.01% 4524
2022
Q3 		$18.6M Buy
391,100
+227,900
+140% +$13M ﹤0.01% 1486
2022
Q2 		$6.32M Buy
163,200
+33,500
+26% +$1.33M ﹤0.01% 2819
2022
Q1 		$7.43M Buy
129,700
+51,100
+65% +$3.35M ﹤0.01% 2974
2021
Q4 		$6.26M Sell
78,600
-19,800
-20% -$1.7M ﹤0.01% 3377
2021
Q3 		$8.56M Sell
98,400
-52,600
-35% -$5.28M ﹤0.01% 3095
2021
Q2 		$19.4M Sell
151,000
-154,800
-51% -$12.3M ﹤0.01% 2064
2021
Q1 		$24.5M Buy
305,800
+199,500
+188% +$19M ﹤0.01% 1661
2020
Q4 		$8.68M Buy
+106,300
New +$5.23M ﹤0.01% 2668

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Susquehanna International Group's BEAM Position: Q1 2026 in Review

Susquehanna International Group increased its Beam Therapeutics (BEAM) stake by 81% in Q1 2026, buying an estimated $2.22M and bringing the position to 178,391 shares worth $4.25M. The position accounts for ﹤0.01% of the portfolio, ranked #4544.

Susquehanna International Group first reported a position in BEAM in Q4 2020 and has held it in 22 quarters since. The position peaked at $10M in Q2 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Susquehanna International Group held 178,391 shares of Beam Therapeutics worth $4.25M as of Q1 2026.
  • Susquehanna International Group bought 79,880 Beam Therapeutics shares in Q1 2026, an estimated $2.22M.
  • Beam Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #4544 holding.
  • Susquehanna International Group first reported a position in Beam Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Beam Therapeutics position peaked at $10M in Q2 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.